Rising Use of Oral Pills to Offer Impetus to Contraceptive Drugs Market Says Market Research Future
The global contraceptive drugs market is expected to touch new high of around USD 22.15 billion at a splendid 6.5% CAGR during the forecast period (2018-2023). Simply put, contraceptive drugs or pills are medicines that help in preventing unwanted pregnancy. It will block the usual ovulation process or alter the process that supports the egg’s fertilization. Patches, combined oral contraceptives, implants, injectables, vaginal rings and intra-uterine devices (IUDs) are the most recent contraceptive methods that is accessible in the market.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1276
Contraceptives drugs refers to the medicines that are used to prevent unwanted pregnancy. Contraceptives drugs consists one or more synthetic female sex hormones, if they contain both estrogen and progestin are known as combined oral contraceptives (COC) and if they contain only progestin are known as progestin-only contraceptives (POP). Both of them have different pattern to prevent pregnancy, combined oral contraceptives (COC) which includes both estrogen and progestin, restrain the normal process of releasing egg from an ovary (ovulation) and by altering the lining of the uterus in result it is unable to support a fertilized egg. Whereas in progestin-only contraceptives (POP) mainly just change the viscosity of mucus and thin the endometrium. The factors which drive the market of contraceptives drugs are increasing need of population controls and increasing prevalence of sexually transmitted diseases. According to report published by World Health Organization (WHO) in 2016, more than 1 million sexually transmitted infections (STIs) are acquired every day worldwide. Additionally, report suggest that more than 500 million people are estimated to have genital infection with herpes simplex virus (HSV).
Leading players profiled in the contraceptive drugs market include Cooper Surgical (US), Mayer Laboratories (US), The Female Health Company (US), Church & Dwight (US), Reckitt Benckiser Plc (UK), Piramal Enterprises Ltd (India), Mankind Pharma Ltd. (India), Janssen Global Services llc. (US), Allergan plc. (Ireland), Bayer AG (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Pfizer Inc (US) and Merck & Co., Inc (US).
Jan 2019- A research conducted by a postdoctoral researcher, Wei Li at Atlanta’s Georgia Institute has introduced an innovative technology which will offer the contraceptive levonorgestrel with the help of a microneedle skin patch. This patch will come with drug-containing needles which will break off post application of the patch for a couple of seconds. This tiny needle will remain under the skin and release the drug. The new technology will allow women in self-administering the long-acting contraceptives within seconds.
Market Research Future report offers an all-inclusive segmental analysis of the contraceptive drugs market on the basis of type and end-user.
Based on type, it is segmented into injectable, oral contraceptive and others. The oral contraceptive segment is further segmented into progestogen-only pills and oral contraceptive pills. Of these, the oral contraceptives segment is expected to have the maximum share in the contraceptive drugs market during the forecast period due to widespread utilization of oral pills by women.
Based on end user, the contraceptive drugs market is segmented into hospitals, clinics and others.
Based on region, the contraceptive drugs market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will command the market due to rising awareness amid people coupled with increase in the rates of abortion. As per the 2015 report published by the Centers for Disease Control and Prevention, approximately 229,715 babies had been born from females aged 15-19 years. Europe also has a favourable share in the contraceptive drugs market due to increasing awareness regarding healthcare industries, well-developed technology and increasing government support. Besides, companies here are mostly into export that will boost up the share of the market across the globe. The APAC and the Middle East and Africa are also likely to have a favorable share. Countries such as China and India will experience the fastest growth in the contraceptive drugs market owing to increasing incidence of pregnancy amid teenagers. As per WHO, the birth rates in adolescents is 45 births/1000 females in South-Eastern Asia while 7 births/1000 females in Eastern Asia. They are open for adopting new treatment choices from developed countries. It is this gap amid the developed countries and the developing countries that will offer growth opportunities for the market players in the near future.
Browse Complete 80 Pages Premium Research Report Enabled with Respective Tables and Figures at @ https://www.marketresearchfuture.com/reports/contraceptive-drugs-market-1276
Table Of Contents
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power Of Suppliers
4.1.2 Bargaining Power Of Customer
4.1.3 Intensity Of Competitor’s
4.1.4 Threat Of New Entrants
Send an Enquiry @ https://www.marketresearchfuture.com/enquiry/1276
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar